Home/Pipeline/Novel PNS System

Novel PNS System

Chronic Pain

First-in-Human CompletedActive

Key Facts

Indication

Chronic Pain

Phase

First-in-Human Completed

Status

Active

Company

Nervonik

About Nervonik

Nervonik is a private, pre-revenue medical device company founded in 2019 and based in San Diego, CA. It is developing a novel, patented PNS platform designed to overcome the technical challenges of delivering neuromodulation in areas of high motion, with the goal of improving lead placement, programming, energy efficiency, and long-term efficacy. The company has successfully completed a first-in-human clinical trial, marking a key translational milestone for its technology. Nervonik is led by a seasoned team with extensive experience in neuromodulation, medical device engineering, and commercialization.

View full company profile

Therapeutic Areas

Chronic Pain

Other Chronic Pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active
Platform Enhancements	Nevro	R&D	Active